Literature DB >> 6377913

Control of glomerular filtration rate: role of intrarenally formed angiotensin II.

P R Kastner, J E Hall, A C Guyton.   

Abstract

This study was designed to investigate the role of intrarenally formed angiotensin II (ANG II) in controlling glomerular filtration rate (GFR) during reduction of renal artery pressure (RAP). The experimental design prevented renin released by the kidney from entering the systemic circulation and therefore prevented changes in circulating ANG II from influencing GFR control. In dogs with only a functional intrarenal renin-angiotensin system (RAS), GFR and renal blood flow (RBF) were not significantly altered by RAP reduction to 70 mmHg. After blockade of intrarenal ANG II formation with SQ 14225, reduction of RAP to 70 mmHg decreased GFR and filtration fraction to 75.6 +/- 7.0 and 59.0 +/- 4.1% of control, respectively, while RBF remained at 129.3 +/- 8.8% of control. Calculated efferent arteriolar resistance decreased considerably more when RAP was reduced after SQ 14225, whereas preglomerular resistance decreased to about the same level as observed prior to SQ 14225 infusion. After return of endogenously produced ANG II by recirculation of the renal venous blood or after infusion of ANG II (following SQ 14225) at a rate that restored RBF to the control level (with RAP held at 70 mmHg in each case), GFR, filtration fraction, and calculated efferent resistance were restored to control levels, but preglomerular resistance did not change. These results suggest that intrarenal ANG II formation plays an important role in maintaining GFR during reductions in RAP by constricting efferent arterioles.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6377913     DOI: 10.1152/ajprenal.1984.246.6.F897

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  21 in total

1.  Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in rats.

Authors:  R Folgert G Haverdings; Marijke Haas; Gerjan Navis; Anne-Miek Van Loenen-Weemaes; Dirk K F Meijer; Dick De Zeeuw; Frits Moolenaar
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

Review 2.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 3.  Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney disease.

Authors:  Ravi Nistala; Yongzhong Wei; James R Sowers; Adam Whaley-Connell
Journal:  Transl Res       Date:  2009-01-23       Impact factor: 7.012

Review 4.  How the kidney is impacted by the perinatal maternal environment to develop hypertension.

Authors:  Ana D Paixão; Barbara T Alexander
Journal:  Biol Reprod       Date:  2013-12-19       Impact factor: 4.285

5.  Low-dose enalapril in severe chronic heart failure.

Authors:  C G Brilla; B Krämer; H M Hoffmeister; W Müller-Schauenburg; T Risler; L Seipel
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

6.  Endothelin-1 in the rabbit: interactions with cyclo-oxygenase and NO-synthase products.

Authors:  M E Rogerson; H S Cairns; L D Fairbanks; J Westwick; G H Neild
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

7.  Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole.

Authors:  S Ito; S Arima; Y L Ren; L A Juncos; O A Carretero
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Angiotensin II and hypertonicity modulate proximal tubular aquaporin 1 expression.

Authors:  Richard Bouley; Zaira Palomino; Shiow-Shih Tang; Paula Nunes; Hiroyuki Kobori; Hua A Lu; Winnie W Shum; Ivan Sabolic; Dennis Brown; Julie R Ingelfinger; Flavia F Jung
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-23

Review 9.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

10.  Angiotensin II in experimental hyperdynamic sepsis.

Authors:  Li Wan; Christoph Langenberg; Rinaldo Bellomo; Clive N May
Journal:  Crit Care       Date:  2009-11-30       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.